Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Rif1 choreographs DNA replication timing
Rif1 Supports the Function of the CST Complex in Yeast Telomere Capping
Rif1 and Rif2 Inhibit Localization of Tel1 to DNA Ends
Rif1 maintains telomeres and mediates DNA repair by encasing DNA ends
Rif1: A Conserved Regulator of DNA Replication and Repair Hijacked by Telomeres in Yeasts
Rif1/2 and Tel1 function in separate pathways during replicative senescence
Rif1 phosphorylation site analysis in telomere length regulation and the response to damaged telomeres
Rif1 acts through Protein Phosphatase 1 but independent of replication timing to suppress telomere extension in budding yeast
Rif2 Promotes a Telomere Fold-Back Structure through Rpd3L Recruitment in Budding Yeast
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
Rifampin Stability in 7H9 Broth and Lowenstein-Jensen Medium
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis
Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer
Rifabutin autoinduction is caused by involvement of cytochrome P450 and cholinesterase
Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures
Rifampicin inhibits apoptosis in rotenone-induced differentiated PC12 cells by ameliorating mitochondrial oxidative stress
Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica
Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T > C polymorphism
Rifampicin-induced severe headache in HIV-tuberculosis coinfected patient
Rifampin-Associated Pseudomembranous Colitis
Rifampicin use in MRSA infections: will it add to the emergence of multidrug-resistant tuberculosis in developing countries?
Rifampicin induces MDR1 expression in Candida albicans
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
Rifapentine and Isoniazid for Latent Tuberculosis REPLY
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis
Rifampicin Plus Colistin in the Era of Extensively Drug-Resistant Acinetobacter baumannii Infections
Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis
Rifampicin-induced lupus erythematosus
日法德高速列车乘坐车厢内饰设计特点分析及启示
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB
Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2 alpha-ATF4 Pathway
Rifaximin for Preventing Acute Graft-Versus-Host Disease: Impact on Plasma Markers of Inflammation and T-cell Activation
Rifaximin Modulates the Vaginal Microbiome and Metabolome in Women Affected by Bacterial Vaginosis
Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region
Rifampin Soaking Dacron-Based Endografts for Implantation in Infected Aortic Aneurysms-New Application of a Time-Tested Principle
Rifaximin Is Largely Safe and Well Tolerated but Caution Is Necessary When Taken With Statins Reply
Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats
Rifaximin for Episodic, Overt Hepatic Encephalopathy: The Data are Catching up to Clinical Practice, but Questions Remain
Rifaximin suppresses background intestinal F-18-FDG uptake on PET/CT scans
Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-beta-Naphthylamide-Inhibitable Efflux Pumps
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
Rifaximin in IBD: Is It Time to Beat Back the Bugs as Induction Therapy in Crohn's Disease?
Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Rifampicin Induced Embryotoxicity in Mus musculus
Rifaximin-Mediated Changes to the Epithelial Cell Proteome: 2-D Gel Analysis
Rifamycin-Associated Postoperative Allergic Contact Dermatitis in a 70-Year-Old Patient
Rifampicin and moxifloxacin for tuberculous meningitis
Rifaximin Is an Efficacious Treatment for the Parkinsonian Phenotype of Hepatic Encephalopathy
Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis
Rifaximin Is Largely Safe and Well Tolerated but Caution Is Necessary When Taken With Statins
Rifampicin improves neuronal apoptosis in LPS-stimulated co-cultured BV2 cells through inhibition of the TLR-4 pathway
Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis
Rifampicin suppresses thymineless death by blocking the transcription-dependent step of chromosome initiation
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations